Andrew Dudum, the Chief Executive Officer of $HIMS ($HIMS), sold 40,553 shares of the company on 01-16-2025 for an estimated $1,093,467. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.8% of their shares of this class of stock. Following this trade, they now own 482,311 shares of this class of $HIMS stock.
$HIMS Insider Trading Activity
$HIMS insiders have traded $HIMS stock on the open market 131 times in the past 6 months. Of those trades, 2 have been purchases and 129 have been sales.
Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:
- ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 33 sales selling 1,701,509 shares for an estimated $33,717,039.
- OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 35 sales selling 606,661 shares for an estimated $14,757,960.
- SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 12 sales selling 292,317 shares for an estimated $7,940,000.
- MELISSA BAIRD (Chief Operating Officer) has made 0 purchases and 20 sales selling 288,660 shares for an estimated $6,399,413.
- MICHAEL CHI (Chief Commercial Officer) has made 0 purchases and 18 sales selling 255,800 shares for an estimated $6,103,166.
- DAVID B WELLS sold 40,000 shares for an estimated $1,199,584
- IRENE BECKLUND (PAO) has made 0 purchases and 7 sales selling 22,388 shares for an estimated $536,614.
- PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 2 sales selling 19,707 shares for an estimated $464,019.
- ANJA MANUEL has made 2 purchases buying 5,000 shares for an estimated $132,259 and 0 sales.
- CHRISTIANE PENDARVIS sold 7,000 shares for an estimated $106,064
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HIMS Hedge Fund Activity
We have seen 167 institutional investors add shares of $HIMS stock to their portfolio, and 135 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 3,808,320 shares (-99.2%) from their portfolio in Q3 2024, for an estimated $70,149,254
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,070,438 shares (+2340.6%) to their portfolio in Q3 2024, for an estimated $38,137,467
- VANGUARD GROUP INC added 1,765,240 shares (+10.7%) to their portfolio in Q3 2024, for an estimated $32,515,720
- MILLENNIUM MANAGEMENT LLC removed 1,735,117 shares (-88.0%) from their portfolio in Q3 2024, for an estimated $31,960,855
- BALYASNY ASSET MANAGEMENT L.P. added 1,700,144 shares (+inf%) to their portfolio in Q3 2024, for an estimated $31,316,652
- AMERIPRISE FINANCIAL INC added 1,494,982 shares (+894.2%) to their portfolio in Q3 2024, for an estimated $27,537,568
- SQUAREPOINT OPS LLC added 1,264,196 shares (+inf%) to their portfolio in Q3 2024, for an estimated $23,286,490
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.